Luisa Guidi

4.3k total citations
131 papers, 2.8k citations indexed

About

Luisa Guidi is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Luisa Guidi has authored 131 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Genetics, 56 papers in Epidemiology and 31 papers in Surgery. Recurrent topics in Luisa Guidi's work include Inflammatory Bowel Disease (72 papers), Microscopic Colitis (44 papers) and Eosinophilic Esophagitis (11 papers). Luisa Guidi is often cited by papers focused on Inflammatory Bowel Disease (72 papers), Microscopic Colitis (44 papers) and Eosinophilic Esophagitis (11 papers). Luisa Guidi collaborates with scholars based in Italy, United States and Japan. Luisa Guidi's co-authors include Alessandro Armuzzi, Alfredo Papa, Daniela Pugliese, Manuela Marzo, I. De Vitis, Antonio Gasbarrini, Carla Felice, Gian Lodovico Rapaccini, Gianluca Andrisani and Giammarco Mocci and has published in prestigious journals such as Blood, Gastroenterology and Radiology.

In The Last Decade

Luisa Guidi

129 papers receiving 2.7k citations

Peers

Countries citing papers authored by Luisa Guidi

Since Specialization

Citations

This map shows the geographic impact of Luisa Guidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Guidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Guidi more than expected).

Fields of papers citing papers by Luisa Guidi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Guidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Guidi. The network helps show where Luisa Guidi may publish in the future.

Co-authorship network of co-authors of Luisa Guidi

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Guidi. A scholar is included among the top collaborators of Luisa Guidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Guidi. Luisa Guidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn’s Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies 2023 ·Journal of Crohn s and Colitis ·(unknown), (unknown), Ewout W. Steyerberg, (unknown), María José Casanova, Guillaume Bouguen, Joyce Wing Yan Mak, Tamás Molnár, Alan Lobo, Jakob Benedict Seidelin, Aurélien Amiot, Geert D’Haens, Pauline Rivière, Luisa Guidi, Renáta Bor, Wei‐Chen Lin, Laurent Peyrin‐Biroulet, Javier P. Gisbert, C. Janneke van der Woude, Annemarie C. de Vries	2
2	Sa1877 EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF SWITCHING FROM ORIGINATOR INFILIXIMAB TO BIOSIMILAR INFLIXIMAB (CT-P13) IN A LARGE COHORT OF IBD PATIENTS 2020 ·Gastroenterology ·Giuseppe Privitera, Daniela Pugliese, Barbara Tolusso, Elisa Gremese, Alfredo Papa, Luigi Giovanni Papparella, Antonio Gasbarrini, Gian Lodovico Rapaccini, Luisa Guidi, Alessandro Armuzzi	1
3	Serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients 2020 ·Alimentary Pharmacology & Therapeutics ·Lorenzo Bertani, Domenico Tricò, Daniela Pugliese, Giuseppe Privitera, Giuseppe Linsalata, Federico Zanzi, M.G. Mumolo, Brigida Barberio, Fabio Monzani, Santino Marchi, Luisa Guidi, Corrado Blandizzi, Alessandro Armuzzi, Francesco Costa	17
4	Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study 2018 ·Gastroenterology Research and Practice ·Daniela Pugliese, Annalisa Aratari, Stefano Festa, Pietro Manuel Ferraro, Rita Monterubbianesi, Luisa Guidi, Maria Lia Scribano, Claudio Papi, Alessandro Armuzzi	8
5	Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study 2017 ·Digestive and Liver Disease ·Marco Daperno, Aurora Bortoli, Anna Kohn, (unknown), Stefano Marconi, Sandro Ardizzone, C.C. Cortelezzi, (unknown), Luca Ferraris, Mónica Milla, Luisa Spina, Luisa Guidi, Alessandra Losco, Gaetano Inserra, Renato Sablich, D Morganti, Giorgia Bodini, Michele Comberlato	7
6	Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti‐TNF alpha: 5‐year follow‐up study 2015 ·Alimentary Pharmacology & Therapeutics ·Daniela Pugliese, Luisa Guidi, Pietro Manuel Ferraro, Manuela Marzo, Carla Felice, Leonardo Celleno, Rosario Landi, (unknown), Fabrizio Pizzolante, I. De Vitis, Alfredo Papa, Gian Lodovico Rapaccini, Alessandro Armuzzi	85
7	Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year 2014 ·Digestive and Liver Disease ·Luisa Guidi, Manuela Marzo, Gianluca Andrisani, Carla Felice, Daniela Pugliese, Giammarco Mocci, Olga Maria Nardone, I. De Vitis, Alfredo Papa, G.L. Rapaccini, Franca Forni, Alessandro Armuzzi	71
8	Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis 2014 ·Inflammatory Bowel Diseases ·Alessandro Armuzzi, Daniela Pugliese, Silvio Danese, Gianluca Rizzo, Carla Felice, Manuela Marzo, Gianluca Andrisani, Gionata Fiorino, Olga Maria Nardone, I. De Vitis, Alfredo Papa, Gian Lodovico Rapaccini, Luisa Guidi	51
9	Infliximab in Steroid-dependent Ulcerative Colitis 2013 ·Inflammatory Bowel Diseases ·Alessandro Armuzzi, Daniela Pugliese, Silvio Danese, Gianluca Rizzo, Carla Felice, Manuela Marzo, (unknown), Gionata Fiorino, (unknown), Alfredo Papa, I. De Vitis, Gian Lodovico Rapaccini, Luisa Guidi	63
10	Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents 2012 ·Journal of Crohn s and Colitis ·Alfredo Papa, Carla Felice, Manuela Marzo, Gianluca Andrisani, Alessandro Armuzzi, Marcello Covino, Giammarco Mocci, Daniela Pugliese, I. De Vitis, Antonio Gasbarrini, Gian Lodovico Rapaccini, Luisa Guidi	64
11	Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants 2012 ·Journal of Crohn s and Colitis ·Gianluca Andrisani, Daniela Frasca, Maria Romero, Alessandro Armuzzi, Carla Felice, Manuela Marzo, Daniela Pugliese, Alfredo Papa, Giammarco Mocci, I. De Vitis, Gian Ludovico Rapaccini, Bonnie B. Blomberg, Luisa Guidi	69
12	Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience 2011 ·International Journal of Colorectal Disease ·Gianluca Rizzo, Alessandro Armuzzi, Daniela Pugliese, Alessandro Verbo, Alfredo Papa, Claudio Mattana, Gian Lodovico Rapaccini, Luisa Guidi, Claudio Coco	61
13	Ileal Crohn Disease: Mural Microvascularity Quantified with Contrast-enhanced US Correlates with Disease Activity 2011 ·Radiology ·Antonio De Franco, (unknown), Alessandro Armuzzi, (unknown), Manuela Marzo, (unknown), I. De Vitis, Alfredo Papa, E Bock, Francesco Danza, Lorenzo Bonomo, Luisa Guidi	70
14	Enteroclysis CT and PEG-CT in patients with previous small-bowel surgical resection for Crohn’s disease: CT findings and correlation with endoscopy 2009 ·European Radiology ·Laura Maria Minordi, A Vecchioli, (unknown), Luisa Guidi, I. De Vitis, Lorenzo Bonomo	37
15	Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn’s disease with anal endosonographic monitoring: a single-centre experience 2008 ·Techniques in Coloproctology ·Luisa Guidi, Carlo Ratto, S Semeraro, (unknown), I. De Vitis, Alfredo Papa, Manuela Marzo, Angelo Parello, (unknown), G. B. Doglietto, Giovanni Battista Gasbarrini, G Fedeli	28
16	Role of DNA-dependent protein kinase in recognition of radiation-induced DNA damage in human peripheral blood mononuclear cells 2001 ·International Immunology ·(unknown), (unknown), (unknown), Luisa Guidi, Luca Pierelli, Gino Doria	12
17	Modulation of X-ray-induced damage recognition and repair in ageing human peripheral blood mononuclear cells by an interleukin-6-type cytokine 2001 ·Mechanisms of Ageing and Development ·Daniela Frasca, (unknown), (unknown), Francesco Guidi, (unknown), Luisa Guidi, Carlo Bartoloni, (unknown), (unknown), (unknown)	3
18	Plasma Thrombin-Antithrombin Complexes, Latent Coagulation Disorders and Metastatic Spread in Lung Cancer: A Longitudinal Study 1996 ·Oncology ·(unknown), Marcello Vangeli, (unknown), Luisa Guidi, (unknown), (unknown), (unknown), (unknown), (unknown), Carlo Bartoloni	10
19	Impairment of lymphocyte activities in depressed aged subjects 1991 ·Mechanisms of Ageing and Development ·Luisa Guidi, Carlo Bartoloni, Daniela Frasca, (unknown), Роберто Пили, (unknown), E. Tempesta, Carlo Rumi, (unknown), Pierugo Carbonin, (unknown), (unknown)	33
20	Longitudinal study of CA 19-9 and CEA in gastrointestinal cancer patients at different stages 1990 ·Carlo Bartoloni, Luisa Guidi, (unknown), (unknown), (unknown), Carlo Garufi, G Gambassi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact